Rxo Inc. (RXO)
NYSE · Industrials
Rxo Inc. EBITDA 2020–2025
Rxo Inc. annual/quarterly ebitda history and growth rate from 2020 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Rxo Inc. ebitda for the quarter ending March 31, 2026 was -2.0 M, a 200.00% decrease year-over-year.
- Rxo Inc. ebitda for the twelve months ending March 31, 2026 was 49.0 M, a 11.36% increase year-over-year.
- Rxo Inc. annual ebitda for 2025 was 37.0 M, a 19.35% increase from 2024.
- Rxo Inc. annual ebitda for 2024 was 31.0 M, a 70.75% decrease from 2023.
- Rxo Inc. annual ebitda for 2023 was 106.0 M, a 49.28% decrease from 2022.
- Rxo Inc. annual ebitda for 2022 was 209.0 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Rxo Inc. EBITDA — FAQ
Rxo Inc. (RXO) ebitda over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RXO's ebitda history?
The chart and table above show Rxo Inc.'s ebitda by year and by quarter, including the growth rate.